Contract notice
Section I: Contracting
authority
I.1) Name and addresses
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Cardiff and Vale University Health Board, Maes-y-Coed Road, Woodlands House
Cardiff
CF14 4HH
UK
Telephone: +44 1443848585
E-mail: jessica.moeran2@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://nwssp.nhs.wales/ourservices/procurement-services/
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://etenderwales.bravosolution.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://etenderwales.bravosolution.co.uk
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Provision of Base Material
II.1.2) Main CPV code
33141520
II.1.3) Type of contract
Supplies
II.1.4) Short description
The NHS Wales Shared Services Partnership, hosted by Velindre NHS Trust are acting on behalf of Cardiff and Vale University Local Health Board for Weqas who seeks to establish a contract for the supply of base material products (serum and plasma products).
II.1.5) Estimated total value
Value excluding VAT:
260 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
Yes
Tenders may be submitted for maximum 4 lots
II.2) Description
Lot No: 1
II.2.1) Title
Single Donor off the clot Serum
II.2.2) Additional CPV code(s)
33141520
II.2.3) Place of performance
NUTS code:
UKL22
II.2.4) Description of the procurement
The serum material to be supplied must be;
a) sterile
b) tested and found negative for HIV, Hepatitis B and Hepatitis C
c) optically clear and free of particulate matter
d) non Haemolysed, non icteric, non turbid
The supplier must be able to provide the age, sex and drug history
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 60
This contract is subject to renewal: Yes
Description of renewals:
The 60 months above includes an option to extend for two 12 month increments at the sole discretion of the Health Board.
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Defibrinated Plasma
II.2.2) Additional CPV code(s)
33141520
II.2.3) Place of performance
NUTS code:
UKL22
II.2.4) Description of the procurement
This Lot is for Defibrinated Plasma. The Plasma material to be supplied must be;
a) sterile
b) optically clear and free of particulate matter.
c) non Haemolysed, non icteric, non turbid
d) easily filtered through a 0.6 & 0.2µm filter
e) provided in containers / bags suitable for freezing to -20°C.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 60
This contract is subject to renewal: Yes
Description of renewals:
The 60 months includes the option to extend for a further two 12 month intervals at the sole discretion of the Health Board
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 3
II.2.1) Title
EDTA Plasma
II.2.2) Additional CPV code(s)
33141520
II.2.3) Place of performance
NUTS code:
UKL22
II.2.4) Description of the procurement
This Lot is for EDTA Plasma. The serum material to be supplied must be;
a) sterile
b) tested and found negative for HIV, Hepatitis B and Hepatitis C
c) optically clear and free of particulate matter
d) serum must be representative of native plasma
The material must be provided in containers / bags suitable for freezing to -20°C
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 60
This contract is subject to renewal: Yes
Description of renewals:
The 60 months includes the option to extend for a further two 12 month intervals at the sole discretion of the Health Board
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 4
II.2.1) Title
Lithium Heparin Serum
II.2.2) Additional CPV code(s)
33141520
II.2.3) Place of performance
NUTS code:
UKL22
II.2.4) Description of the procurement
This Lot is for Lithium Heparin Plasma. The material to be supplied must be;
a) sterile
b) tested and found negative for HIV, Hepatitis B and Hepatitis C
c) optically clear and free of particulate matter
d) serum must be representative of native plasma
e) the manufacturer must provide 15 ml aliquots of the material for testing prior to acceptance
f) material must be provided in containers / bags suitable for freezing to -20°C.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 60
This contract is subject to renewal: Yes
Description of renewals:
The 60 months includes the option to extend for a further two 12 month intervals at the sole discretion of the Health Board
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
07/05/2024
Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
CY
IV.2.7) Conditions for opening of tenders
Date:
07/05/2024
Local time: 12:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.2) Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.3) Additional information
Please note additional information on this procurement:
1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract.
2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the ITT and that save for matters of clarification or consistency the Contracting Authority will not negotiate the terms.
3. The Contracting Authority will not accept completed ITT's after the stated closing date.
4. All documents to be priced (where applicable) in sterling and all payments made in sterling.
5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders.
6. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale University Local Health Board
NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at http://www.sell2wales.gov.wales/search/search_switch.aspx?ID=140516
(WA Ref:140516)
VI.4) Procedures for review
VI.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Telephone: +44 2079477501
VI.5) Date of dispatch of this notice
08/04/2024